Experimental Pathology, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Medicine I, University Hospital and Faculty of Medicine, Technical University Dresden, Dresden, Germany.
J Natl Cancer Inst. 2023 Jun 8;115(6):608-612. doi: 10.1093/jnci/djad048.
Pathologists worldwide are facing remarkable challenges with increasing workloads and lack of time to provide consistently high-quality patient care. The application of artificial intelligence (AI) to digital whole-slide images has the potential of democratizing the access to expert pathology and affordable biomarkers by supporting pathologists in the provision of timely and accurate diagnosis as well as supporting oncologists by directly extracting prognostic and predictive biomarkers from tissue slides. The long-awaited adoption of AI in pathology, however, has not materialized, and the transformation of pathology is happening at a much slower pace than that observed in other fields (eg, radiology). Here, we provide a critical summary of the developments in digital and computational pathology in the last 10 years, outline key hurdles and ways to overcome them, and provide a perspective for AI-supported precision oncology in the future.
全世界的病理学家都面临着巨大的挑战,包括工作量不断增加和缺乏时间来提供始终如一的高质量患者护理。人工智能 (AI) 在数字全切片图像中的应用有可能通过支持病理学家提供及时准确的诊断,并通过直接从组织切片中提取预后和预测生物标志物来支持肿瘤学家,从而实现专家病理学和负担得起的生物标志物的普及。然而,人们期待已久的 AI 在病理学中的应用并没有实现,病理学的转变速度比其他领域(例如放射学)要慢得多。在这里,我们对过去 10 年数字和计算病理学的发展进行了批判性总结,概述了关键障碍及其克服方法,并为未来人工智能支持的精准肿瘤学提供了展望。